Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2007
Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and miceEric C K Siu, Rachel F TyndaleAnnual Review of Pharmacology and Toxicology|January 11, 2007
Non-nicotinic therapies for smoking cessationEric C K Siu, Rachel F TyndaleMolecular Pharmacology|December 13, 2006
Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 miceEric C K Siu, Rachel F TyndalePsychopharmacology|February 18, 2006
Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5Eric C K Siu, Dieter B Wildenauer, Rachel F TyndaleNicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 26, 2013
Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitorShakir D Alsharari, Eric C K Siu, Rachel F Tyndale, et al.Psychopharmacology|April 4, 2008
Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar ratsMegan J Shram, Eric C K Siu, Zhaoxia Li, et al.Pageof 1